BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2002
View Archived Issues
Drug pipeline for sleep disorders
Read More
Several related series of antidepressants under development at Wyeth
Read More
Celltech presents novel receptor tyrosine kinase inhibitors for cancer, psoriasis, etc.
Read More
Aventis claims CDK2 inhibitors for cancer and chemotherapy-induced neuronal apoptosis
Read More
Novel glucocorticoids in early development at GSK
Read More
Aventis discovers antiarrhythmic Kv1.5 channel blockers
Read More
New inhibitors of fatty acid amide hydrolase with utility in neuropathic pain
Read More
Vertex describes the preparation and use of novel beta-secretase inhibitors
Read More
Promising toxicity and antitumor efficacy for temozolomide + vatalanib succinate in glioblastoma
Read More
Potential use of TP-38 in recurrent malignant brain tumors
Read More
Improved survival rate found with 131I-ch81C6 in malignant brain tumors
Read More
SU-11248: preclinical and early clinical findings encourage further development
Read More
Telomerase inhibitor with potential as an antitumor and radiosensitizing agent
Read More
Sulfonyhydrazine prodrug VNP-40101M advances towards phase II clinical evaluation
Read More
Corixa withdraws dispute resolution as FDA returns Bexxar to active review status
Read More
Human Genome Sciences and Kirin announce license agreement
Read More
Taxotere approved for first-line therapy in NSCLC
Read More
Lexapro oral solution provides new option for depressed patients
Read More
Approvable letter for Pennsaid in Canada
Read More
Axcan receives approvable letter for Photofrin
Read More
Enrollment completed in phase III trial of ABI-007
Read More
Genetronics and Chiron extend collaboration to test HIV vaccine delivery
Read More
Mercury Therapeutics licenses oncology target from Mass General
Read More
Milestone reached in Mercury Therapeutics and Aventis AMPK collaboration
Read More
Antibody product enters phase I for autoimmune disease
Read More